Page 10 - Gireesh Babu

Markab Capital to acquire controlling stake in Uniply Industries

Markab Capital and its wholly-owned Indian subsidiary, Markab India SPV Pvt Ltd, have acquired 20.7 per cent shareholding from the promoter Keshav Kantamneni and his group entities at Rs 82 per share

Anil Agarwal's Vedanta sees foreign hand in Sterlite Copper closure

Sterlite Copper paid the government around Rs 2,200 crore as tax

NCLT approves okays Dhanuka Laboratories' resolution plan for Orchid Pharma

Creditors to get Rs 1,116 crore, which is lower than liquidation value

Madras HC dismisses Cognizant's plea over Rs 2,800 crore tax demand

The company was accused of evading DDT on transactions made while buying shares from its Mauritius and US arms

Financial creditors of Orchid Pharma likely to see larger haircut

A total of 24 financial creditors have an accepted claim of around Rs 3,390 crore from Orchid Pharma

Ready to revise resolution plan for Orchid Pharma: Accord to NCLT

Chennai-based Accord Life Spec Pvt Ltd on Wednesday told the tribunal that it was ready to revise its proposal to Rs 615 crore

NCLT okays first resolution plan in realty; Oasis to invest in Vishwakarma

Sanjay Chugh, head of Chennai branch of Anarock Property Consultants, said the NCLT's okaying the resolution plan would boost the confidence in the sector

Boost to Biocon's biosimilar business as Bengaluru units get European nod

Facilities were inspected by the European Medicines Agency in March; Analysts foresee firm posting double-digit growth in revenue and profits despite rising competition

Dhanuka Lab bid for Orchid Pharma hits new wall as one lender changes vote

Punjab National Bank (International) Limited dissents minutes before e-voting closes, taking the assents to below the 66% threshold

Dhanuka Lab bid for Orchid Pharma hits new wall as one lender changes vote

Punjab National Bank (International) Limited dissents minutes before e-voting closes, taking the assents to below the 66% threshold

Two-thirds of lenders have voted for Dhanuka Laboratories' resolution

The banks are expecting a haircut of 35-40 per cent

DPIIT says FDI flow into Tamil Nadu declines 25%, state refutes data

Overall FDI inflow declined to $44.37 billion (Rs 309,867 crore) in 2018-2019 from $44.86 billion in the previous year (Rs 288,889 crore)

Freshworks partners OrangeOne Corporation to expand business in Japan

Freshworks has an extensive partner and reseller network in the APAC region covering prominent countries like Singapore, Malaysia and Thailand

PharmEasy may soon close $100-mn funding round backed by existing investors

The new round is expected to see participation from Avendus Capital, Eight Roads Ventures India, F-Prime Capital, among others

Three pharma firms in second race for Orchid Pharma resolution process

Sources say Dhanuka Laboratories has an edge over the other two, Chennai-based Accord Life Spec and Covalent Labs

Apollo Hospitals aims to reduce promoter group pledged shares by 50%

The promoters have already released around 10 per cent of their pledge

Apollo Hospitals Q4 net profit grows 29%, new hospitals show higher growth

The growth in revenue during the quarter was aided by the 15% year on year (YoY) growth in healthcare services and 18% growth in standalone pharmacy business

Ingen Capital's fresh resolution plan for Orchid Pharma rejected again

The RP said Ingen Capital didn't give any earnest money deposit and neither did it provide "essential details" on how is it going to arrange funds

Stalin's election success unlikely to shake up Tamil Nadu politics soon

Experts are of the view that Palaniswami's tactics to bring in the PMK and others into its alliance has worked well and now he may be able to consolidate his power in the party

Palaniswami gets seats he needed, Stalin may have to work harder next term

AIADMK wins the crucial nine seats that will help it prove majority on the floor, despite the fact that DMK took the other 13 seats